Orphan Drugs Pharmaceuticals imports and distributes orphan drugs, so named because they are not produced and/or developed by laboratories in large commercial lots, and are intended to treat rare diseases of a small group of patients, who are generally ignored or unattended.

Patients diagnosed with a rare disease are usually unaware of the procedures required to gain access to orphan drugs, and Orphan Drugs provides comprehensive accompaniment to patients in this regard, in order to cover the legal and regulatory procedures required by law in each case, in order to obtain their medical treatment in a timely fashion.